About Clarivate JCR-based Journal Impact Factors 2025
The Journal Impact Factor is a journal-level bibliometric indicator published by Clarivate in Journal Citation Reports (JCR). It is often abbreviated as JIF; JIF is not a separate impact factor, but simply the abbreviation for Journal Impact Factor.
The 2025 Journal Impact Factor provides a journal-level indication of citation activity. It should be interpreted within the journal’s subject area and together with other information, rather than used as a stand-alone judgment of research quality.
On this website, you can explore Journal Impact Factor records presented as Clarivate JCR-based data, together with the five-year Impact Factor, JCR quartile (Q1–Q4), JCR category rank, publisher details and journal identifiers. Verify important submission or evaluation decisions in the official Clarivate Journal Citation Reports.
Explore by research area
Browse journals by subject
Start with a broad research area, then narrow the list to a specialty or subsubject. These internal subject groups are provided for discovery and are kept separate from official Journal Citation Reports categories.
Popular specialties
Explore medical journal specialties
Browse focused journal lists within Medicine, including citation metrics, quartiles, publishers and identifiers.
Browse journal metrics
Showing records 5,231–5,240 of 20,480
| Rank | Journal | ISSN / eISSN | JCR Impact Factor | 5-Year Impact Factor | JCR Quartile | JCR Category Rank | Publisher |
|---|---|---|---|---|---|---|---|
| 5,149 |
Current Infectious Disease Reports CURR INFECT DIS REP |
1523-3847 1534-3146 |
2.900 | 3.100 | Q2 | 52/137 | SPRINGER |
| 5,149 |
Current Molecular Pharmacology CURR MOL PHARMACOL |
1874-4672 1874-4702 |
2.900 | 3.100 | Q2 | 150/352 | BENTHAM SCIENCE PUBL LTD |
| 5,149 |
CURRENT OPINION IN HEMATOLOGY CURR OPIN HEMATOL |
1065-6251 1531-7048 |
2.900 | 2.900 | Q2 | 34/98 | LIPPINCOTT WILLIAMS & WILKINS |
| 5,149 |
Current Urology Reports CURR UROL REP |
1527-2737 1534-6285 |
2.900 | 2.800 | Q2 | 34/133 | SPRINGER |
| 5,149 |
Democratization DEMOCRATIZATION |
1351-0347 1743-890X |
2.900 | 4.500 | Q1 | 54/322 | ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD |
| 5,149 |
Discover Oncology DISCOV ONCOL |
N/A 2730-6011 |
2.900 | 3.000 | Q2 | 153/326 | SPRINGER |
| 5,149 |
DNA RESEARCH DNA RES |
1340-2838 1756-1663 |
2.900 | 3.800 | Q2 | 76/191 | OXFORD UNIV PRESS |
| 5,149 |
DOCUMENTA OPHTHALMOLOGICA DOC OPHTHALMOL |
0012-4486 1573-2622 |
2.900 | 1.900 | Q1 | 22/98 | SPRINGER |
| 5,149 |
Drug and Alcohol Dependence Reports DRUG ALC DEPEND REP |
2772-7246 2772-7246 |
2.900 | 2.800 | Q2 | 16/58 | ELSEVIER |
| 5,149 |
Earth Surface Dynamics EARTH SURF DYNAM |
2196-6311 2196-632X |
2.900 | 3.600 | Q2 | 23/67 | COPERNICUS GESELLSCHAFT MBH |